Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

SWOT

STRENGTH WEAKNESS
 1) Kodak has strong  Kodak has poor brand
technological and chemical recognition with current
production capabilities markets/consumers
 Kodak has a strategic focus  Kodak has uncertainties
on producing quality regarding their ability to repay
products, that align with their debts
their production  Kodak has outdated
capabilities. manufacturing technology and
 Kodak has a capable equipment. (
workforce that has been  Kodak lacks consumerbased
able to produce both support, relying solely on B2B
quality products and can production
produce on the large scale.

OPPORTUNITY  Kodak has the chemical  Without a customeroriented


and technological capacity side of their business, Kodak is
· Growth in the to create American- solely relying on their
pharmaceutical market produced APIs which are production. Without a
relating to the pandemic, in high demand within the relationship with consumers, a
including an increased rapidly growing fault in production could be
demand for American pharmaceutical market. more costly than it otherwise
produced APIs  Kodak's emphasis on would
quality production and
FDA grants and funding products could make them
available for new eligible for grants from the
manufacturing methods FDA for pharmaceutical
of APIs production.

THREAT  As Kodaks primary market  As the company ages, so does


continues to decline, they Kodaks equipment, which has
 Pharmaceuticals is a must be cautious not been regularly updated.
highly saturated regarding their brand Within highly regulated
market, with high image, as a complete markets, declining production
levels of competition change of market focus quality can pose many issues,
 Decline in the printing could negatively impact threatening shut down if
and photography longstanding consumers machinery affects quality
markets. (photography) opinion of assurance
 High levels of the brand.  Kodak's debt repayment
regulation regarding uncertainties are further
the production of exploited by their focus within
APIs (FDA) a declining market, with fewer
opportunities for growth and
revenue

You might also like